X1 Biotech Inc., 2026-06-15
An SEC Form D private-offering notice from Needham, MA, a $2,000,000 filer-stated offering target in Biotech. Filed 2026-06-15. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Developing X101, a repurposed small molecule RUNX1 inhibitor for CADASIL, with potential expansion into other vascular diseases.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- DWTRW LTH LLC, 2026-06-16, $5M, Boston, MA
- Peptaris, Inc., 2026-06-16, $4M, Philadelphia, PA
- TMJ LTH LLC, 2026-06-16, $5.5M, Boston, MA
- Memento Medicines, Inc., 2026-06-16, $93M, Boston, MA
- Datalign Advisory, Inc., 2026-06-16, $800K, Cambridge, MA
- CND Life Sciences, Inc., 2026-06-16, $6.3M, Scottsdale, AZ
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.